Lisa O'Neill
|
December 11, 2023
Lisa O'Neill
|
December 11, 2023
A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer’s Disease Ameliorates Functional and Cognitive Outcomes
Lisa O'Neill
|
December 11, 2023
Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug?
Lisa O'Neill
|
December 4, 2023